Pms Cytarabine

Cytarabine is available as an intrathecal (into the space between the layers of tissue covering the brain and spinal cord) injection, subcutaneous (under the skin) injection, and an intravenous (into a vein) injection. The recommended dose of cytarabine and how the cytarabine is used varies according to the specific condition being treated, the response to therapy, the other medications used, the stage of the cancer, and body size.

When given into a vein, it is usually injected through a site on your skin specially prepared for this purpose. Very careful handling of Pms Cytarabine is required. It is always administered in a hospital or similar setting with access to sterile equipment for preparation.

The schedule of dosing depends on which other medications are being used (if any). Usually treatments are given on a daily basis for a period of time followed by a rest period and then the treatment schedule is repeated.

Many things can affect the dose of medication that a person needs, such as body weight, other medical conditions, and other medications. If your doctor has recommended a dose different from the ones listed here, do not change the way that you are taking the medication without consulting your doctor.

It is important Pms Cytarabine be given exactly as recommended by your doctor. If you miss an appointment to receive cytarabine, contact your doctor as soon as possible to reschedule your appointment.

As well as interfering with the genetic material of cancer cells, cytarabine can interfere with some of your normal cells. This may cause a number of side effects such as mouth sores. Keep track of any side effects and report them to your doctor.

Do not dispose of medications in wastewater (e.g. down the sink or in the toilet) or in household garbage. Ask your pharmacist how to dispose of medications that are no longer needed or have expired.

20 mg/mL
Each mL of sterile solution contains 20 mg of cytarabine. Nonmedicinal ingredients: sodium chloride, hydrochloride acid and/or sodium hydroxide to adjust pH, and water for injection.

100 mg/mL
Each mL of sterile solution contains 100 mg of cytarabine. Nonmedicinal ingredients: hydrochloride acid and/or sodium hydroxide to adjust pH, and water for injection.

Do not use Pms Cytarabine if you are allergic to cytarabine or any ingredients of the medication.

There may be an interaction between cytarabine and any of the following:

• amphotericin B
• BCG
• Clozapine
• corticosteroids (e.g., budesonide, Dexamethasone, Hydrocortisone, fluticasone, Prednisone)
• Cyclosporine
• Deferiprone
• dipyrone
• Denosumab
• Digoxin
• echinacea
• Fingolimod
• flucytosine
• gentamicin
• Hydroxyurea
• Leflunomide
• mycophenolate
• Natalizumab
• Nivolumab
• other medications to treat cancer (e.g., Carboplatin, Cyclophosphamide, Doxorubicin, Ifosfamide, Vincristine)
• Pimecrolimus
• Rituximab
• Roflumilast
• Tacrolimus
• Trastuzumab
• Tofacitinib
• vaccines

If you are taking any of these medications, speak with your doctor or pharmacist. Depending on your specific circumstances, your doctor may want you to:

• stop taking one of the medications,
• change one of the medications to another,
• change how you are taking one or both of the medications, or
• leave everything as is.

An interaction between two medications does not always mean that you must stop taking one of them. Speak to your doctor about how any drug interactions are being managed or should be managed.

Medications other than those listed above may interact with Pms Cytarabine. Tell your doctor or prescriber about all prescription, over-the-counter (non-prescription), and herbal medications you are taking. Also tell them about any supplements you take. Since caffeine, alcohol, the Nicotine from cigarettes, or street drugs can affect the action of many medications, you should let your prescriber know if you use them.

Before you begin using a medication, be sure to inform your doctor of any medical conditions or Allergies you may have, any medications you are taking, whether you are pregnant or breast-feeding, and any other significant facts about your health. These factors may affect how you should use Pms Cytarabine.

Anemia: Cytarabine may cause low levels of red blood cells. If you experience symptoms of reduced red blood cell count (anemia) such as shortness of breath, feeling unusually tired, or pale skin, contact your doctor as soon as possible.

Your doctor will do blood tests regularly to monitor the number of specific types of blood cells, including red blood cells, in your blood.

Blood clotting: Pms Cytarabine can reduce the number of platelet cells in the blood. Platelets help the blood to clot, and a shortage could make you bleed more easily. Tell your doctor if there are any signs that your blood is not clotting as quickly as usual. Such symptoms may include black and tarry stools, blood in the urine, easy bruising, or cuts that won't stop bleeding.

Infection: As well as killing cancer cells, Pms Cytarabine can reduce the number of cells that fight infection in the body (white blood cells). If possible, avoid contact with people who have contagious infections. Tell your doctor immediately if you notice signs of an infection, such as fever or chills, severe diarrhea, shortness of breath, prolonged dizziness, headache, stiff neck, weight loss, or listlessness.

Kidney function: Kidney Disease or reduced kidney function may cause Pms Cytarabine to build up in the body, causing side effects. If you have reduced kidney function or kidney disease, discuss with your doctor how Pms Cytarabine may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Pms Cytarabine, and whether any special monitoring is needed.

Liver function: Liver disease or reduced liver function may cause Pms Cytarabine to build up in the body, causing side effects. If you have liver problems, discuss with your doctor how Pms Cytarabine may affect your medical condition, how your medical condition may affect the dosing and effectiveness of Pms Cytarabine, and whether any special monitoring is needed. Your doctor may want to test your liver function regularly with blood tests while you are taking Pms Cytarabine.

If you experience symptoms of liver problems such as fatigue, feeling unwell, loss of appetite, nausea, yellowing of the skin or whites of the eyes, dark urine, pale stools, abdominal pain or swelling, and itchy skin, contact your doctor immediately.

Lung inflammation: Lung inflammation (interstitial lung disease), causing difficulty breathing has occurred rarely in some people taking Pms Cytarabine. This complication can be serious and sometimes fatal. If you experience new or worsening shortness of breath or cough (with or without fever) at any time while you are taking cytarabine, contact your doctor immediately.

Pancreatitis: Pms Cytarabine can cause the pancreas to become inflamed. Report signs of pancreatitis such as abdominal pain on the upper left side, back pain, nausea, fever, chills, rapid heartbeat, or swollen abdomen to your doctor immediately.

Tumour Lysis Syndrome: Cytarabine, like many other cancer medications, causes many cancer cells to be suddenly killed when treatment is first started. This can overwhelm the body with waste products from the cells. As a result, the body may not be able to keep up with getting rid of all the waste. When this happens, you may experience nausea, shortness of breath, cloudy urine, or joint pain. This is called tumour lysis syndrome. Your doctor may prescribe some medications to help your body get rid of the waste products. Make sure you understand how to use these medications and report any of these signs or symptoms to your doctor immediately.

Pregnancy: There is a possibility of birth defect if either the father or the mother is using cytarabine at the time of conception, or if it is taken during pregnancy. Effective birth control should be practiced while using Pms Cytarabine. Tell your doctor immediately if you become pregnant while using Pms Cytarabine. It should only be used during pregnancy if potential benefits clearly outweigh the risks.

Breast-feeding: It is not known whether cytarabine passes into breast milk. If you are a breast-feeding mother and are taking Pms Cytarabine, it may affect your baby. Because of the risks associated with Pms Cytarabine, a decision should be made to stop breast-feeding or stop taking the medication, taking into account the importance of the medication to the mother. Talk to your doctor about whether you should continue breast-feeding.

Children: The safety and effectiveness of using Pms Cytarabine have not been established for children less than 1 year of age.